Jonathan Violin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ASTRIA THERAPEUTICS, INC. 75 State Street, Suite 1400 Boston, MA 02109 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS ...

Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Rating) has been given a consensus recommendation of “Buy” by the thirteen research firms that are currently covering the company, MarketBeat.com reports. Ten research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokerages that have updated their coverage on the stock in […]

Wells Fargo & Company assumed coverage on shares of Viridian Therapeutics (NASDAQ:VRDN – Get Rating) in a research note issued to investors on Monday morning, The Fly reports. The firm issued an overweight rating and a $46.00 target price on the stock. Other equities analysts also recently issued research reports about the company. Stifel Nicolaus […]

MetLife Investment Management LLC raised its holdings in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Rating) by 44.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,843 shares of the company’s stock after acquiring an additional 6,129 shares during the quarter. […]

Trevena (NASDAQ:TRVN – Get Rating) and Merck & Co., Inc. (NYSE:MRK – Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk and profitability. Insider and Institutional Ownership 72.9% of Merck & Co., […]